Minerva Neurosciences, Inc. (NERV) Operating cash flow 2016–2025
Minerva Neurosciences, Inc. (NERV) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$13.5MFY2025 · since FY2016: -$25.7M → -$13.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$13.5M | +30.9% |
| FY2024 | -$19.6M | -32.2% |
| FY2023 | -$14.8M | +40.0% |
| FY2022 | -$24.6M | -0.2% |
| FY2021 | -$24.6M | +27.3% |
| FY2020 | -$33.8M | +22.1% |
| FY2019 | -$43.4M | -3.6% |
| FY2018 | -$41.9M | -1456.1% |
| FY2017 | $3.1M | +112.0% |
| FY2016 | -$25.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NERV financial trends
NERV RevenueNERV Net incomeNERV Net marginNERV Gross profitNERV Gross marginNERV Operating incomeNERV Operating marginNERV Free cash flowNERV Capital expendituresNERV Return on equityNERV Stock buybacksNERV Dividends paidNERV Total assetsNERV Total liabilitiesNERV Shareholders’ equityNERV overview →